1-5 of 5
Troy Z. Horvat, PharmD, BCOP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Outcomes of Acute Myeloid Leukemia Patients Bridged to Allogeneic Stem Cell Transplant By Venetoclax Combination Therapy

Maximilian Stahl, MD, Kamal Menghrajani, MD, Andriy Derkach, PhD, Susan DeWolf, MD, Josel D Ruiz, MPH, Doris M Ponce, MD, Brian C. Shaffer, MD, Roni Tamari, MD, James W. Young, MD, Juliet Barker, MBBS, Ann A. Jakubowski, MDPhD, Boglarka Gyurkocza, MD, Alexander Chan, Wenbin Xiao, MD PhD, Jacob L Glass, MDPhD, Amber C. King, PharmD, BCOP, Sheng F Cai, MDPhD, Anthony Daniyan, MD, Christopher Famulare, MS, Bernadette M. Cuello, BSN, MSN, NP, RN, Troy Z. Horvat, PharmD, BCOP, Eytan M. Stein, MD, Mikhail Roshal, MD PhD, Sergio Giralt, MD, Miguel-Angel Perales, MD, Christina Cho, MD, Martin S. Tallman, MD, Aaron D Goldberg, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-137749
Published: 2020
Journal Articles

Risk of Hyponatremia and Associated Clinical Characteristics in Patients with Acute Lymphoblastic Leukemia after CD19 Targeted Chimeric Antigen Receptor (CAR) T-Cells

Brianne N. Dixon, PharmD, Ryan J. Daley, PharmD, BCOP, Troy Z. Horvat, PharmD, BCOP, Larry W Buie, PharmD, BCOP, FASHP, Meier Hsu, MS, Sheron Latcha, MD, Renier J. Brentjens, MD PhD, Jae H. Park, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3584.
https://doi.org/10.1182/blood.V130.Suppl_1.3584.3584
Published: 2017
Journal Articles

Biomarkers for Predicting Toxicity and Response in Adult Acute Lymphoblastic Leukemia (ALL) Patients Treated with Blinatumomab

Amber C. King, PharmD, BCOP, Ryan J. Daley, PharmD, BCOP, Troy Z. Horvat, PharmD, BCOP, Meier Hsu, MS, Jae H. Park, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3883.
https://doi.org/10.1182/blood.V130.Suppl_1.3883.3883
Published: 2017
Journal Articles

Venetoclax Combined with Either a Hypomethylating Agent or Low-Dose Cytarabine Shows Activity in Relapsed and Refractory Myeloid Malignancies

Aaron D Goldberg, MD, Troy Z. Horvat, PharmD, BCOP, Meier Hsu, MS, Sean M. Devlin, PhD, Bernadette M. Cuello, BSN, MSN, NP, RN, Ryan J. Daley, PharmD, BCOP, Amber C. King, PharmD, BCOP, Larry W Buie, PharmD, BCOP, FASHP, Jacob L Glass, MDPhD, Michael J. Mauro, MD, Eytan M. Stein, MD, Ellin Berman, MD, Virginia M. Klimek, MD, Martin S. Tallman, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1353.
https://doi.org/10.1182/blood.V130.Suppl_1.1353.1353
Published: 2017
Journal Articles

Erwinia Asparaginase Safety and Feasibility during Therapy for Acute Lymphoblastic Leukemia in Adult Patients with Pegaspargase Hypersensitivity or Severe Toxicity

Troy Z Horvat, PharmD, BCOP, Joshua J Pecoraro, PharmD, BCOP, Ryan J Daley, PharmD, BCOP, Larry W Buie, PharmD, BCOP, Dan Douer, MD
Journal: Blood
Blood (2015) 126 (23): 4915.
https://doi.org/10.1182/blood.V126.23.4915.4915
Published: 2015